Palo Alto California based Base5 Genomics is raising $4,210,921.00 in New Equity Investment.
Palo Alto, CA – According to filings with the U.S. Securities and Exchange Commission, Base5 Genomics is raising $4,210,921.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Solomon Endlich played…